NGNE position history
The shares of Neurogene (NGNE) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q2: 11,000 shares, $400K, 0.10% of portfolio, New
- 2024 Q3: 7,775 shares, $326K, 0.08% of portfolio, Reduce −29.3%
- 2024 Q4: 51,500 shares, $1.2M, 0.30% of portfolio, Add +562.4%
- 2025 Q1: 51,500 shares, $603K, 0.17% of portfolio
- 2025 Q2: 51,096 shares, $764K, 0.21% of portfolio, Reduce −0.8%
- 2025 Q3: 30,375 shares, $526K, 0.13% of portfolio, Reduce −40.6%
- 2025 Q4: 27,974 shares, $576K, 0.13% of portfolio, Reduce −7.9%
- 2026 Q1: 56,635 shares, $1.1M, 0.26% of portfolio, Add +102.5%
- 2026 Q2: 89,032 shares, $2.8M, 0.53% of portfolio, Add +57.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|